However, the prognostic impact of FOXP3 is controversial with a number of studies highlighting its association with the poor prognosis of OSCC and HNSCC patients [20,21], while others indicate the association of FOXP3 with a longer overall survival [22,23,24]. Here, FOXP3 is linked to head and neck squamous cell carcinoma.